Elevated levels of galectin-3 in the bloodstream have been correlated with heart failure (HF), negative cardiac remodeling, myocardial fibrosis, atrial fibrillation, and coronary artery disease (CAD). This evidence concerns the gene LGALS3 and heart failure.